Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Match Group Inc old

Start price
Target price
Perf. (%)
€94.85
20.10.20
€100.00
04.11.20
-
04.11.20

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Strong uniques
buy
Alfen

Start price
Target price
Perf. (%)
€62.60
20.10.20
€70.00
04.11.21
6.87%
23.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
ROE higher than 10% per year
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€3.02
19.10.20
€1.00
31.10.20
-33.77%
31.10.20

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Revenue decline/stagnation expected
buy
Farfetch Ltd

Start price
Target price
Perf. (%)
€23.40
19.10.20
€27.00
31.10.20
4.27%
31.10.20

Top 10 in its market
Known brand
Probably not worthwhile Investment
Low dividend yield expected
buy
Apple Inc.

Start price
Target price
Perf. (%)
€100.68
19.10.20
€90.00
04.11.21
-0.08%
11.11.20

Known brand
Could be worthwhile Investment >10% per year
Fair valuation
Innovative
buy
Allianz SE VNA

Start price
Target price
Perf. (%)
€164.18
19.10.20
€240.00
04.11.21
22.70%
05.11.21

Could be very worthwhile Investment >20% year
Very high dividend yield expected
Top Rating
Very capable Management
BIMI International Medical Inc

Start price
Target price
Perf. (%)
€10.50
19.10.20
€5.00
04.11.21
-70.48%
05.11.21

Risky Investment
buy
Apple Inc.

Start price
Target price
Perf. (%)
€101.86
19.10.20
-
04.11.21
7.11%
20.06.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Capable Management
buy
Apple Inc.

Start price
Target price
Perf. (%)
€101.86
19.10.20
-
04.11.21
29.12%
05.11.21

Could be worthwhile Investment >10% per year
Very capable Management
Very good company culture
Market Leader or Top 3
Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
€4.00
30.10.20
14.26%
30.10.20

Probably not worthwhile Investment
buy
Evotec SE

Start price
Target price
Perf. (%)
€23.57
19.10.20
-
04.11.21
25.20%
11.03.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
buy
Nel ASA

Start price
Target price
Perf. (%)
€1.73
19.10.20
-
04.11.21
38.45%
11.03.21

Could be worthwhile Investment >10% per year
Jumia Technologies AG

Start price
Target price
Perf. (%)
€12.80
19.10.20
-
04.11.21
24.22%
05.11.21

EBIT growth >5% per year expected
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
-
04.11.21
-72.31%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Yum! Brands Inc.

Start price
Target price
Perf. (%)
€84.33
19.10.20
-
04.11.21
4.54%
26.12.20

Probably not worthwhile Investment
Revenue decline/stagnation expected
Increased challenges to pay loans and raise capital
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€9.65
19.10.20
€12.00
02.11.20
12.95%
02.11.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€12.20
19.10.20
€15.00
02.11.20
-6.56%
02.11.20

Could be worthwhile Investment >10% per year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€16.30
19.10.20
€20.00
02.11.20
-0.61%
02.11.20

Could be very worthwhile Investment >20% year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
19.10.20
€10.00
02.11.20
-
02.11.20

Could be very worthwhile Investment >20% year
buy
Epigenomics AG NA

Start price
Target price
Perf. (%)
€0.51
18.10.20
€1.00
02.11.20
20.00%
02.11.20

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Innovative
Maxeon Solar Technologies Ltd.

Start price
Target price
Perf. (%)
€14.30
18.10.20
€7.00
04.11.21
21.33%
26.06.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
GNI Group Ltd

Start price
Target price
Perf. (%)
€24.00
18.10.20
€12.00
04.11.21
-35.42%
26.06.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
Below average Management
Little innovation
EAC Invest A/S

Start price
Target price
Perf. (%)
€645.30
18.10.20
€300.00
04.11.21
129.35%
26.06.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€5.70
18.10.20
€2.00
04.11.21
-35.79%
26.06.21

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Enapter AG

Start price
Target price
Perf. (%)
€60.00
18.10.20
€20.00
04.11.21
-54.00%
26.06.21

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation